Paclitaxel is a chemotherapy drug commonly used to treat breast and ovarian cancer, but some tumours can become resistant over time and start growing again.
2
一旦卵巢癌对多种化疗药物产生耐药，则治疗的选择余地较少，而随后治疗的关键在于延长患者的生存期。
Once ovarian cancer becomes resistant to multiple types of chemotherapy, fewer treatment options exist and the focus becomes lengthening patients' survival periods.
3
结论CD147反义核酸能抑制卵巢癌的转移和成瘤，因而有可能成为卵巢癌的治疗的药物靶点。
CONCLUSION CD147 antisense RNA can inhibit invasion and tumorigenesis of ovarian cancer cells and CD147 may become a new drug target of tumor therapy.
点击反馈